Behrouz Shademan
Overview
Explore the profile of Behrouz Shademan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nourazarian A, Yousefi H, Biray Avci C, Shademan B, Behboudi E
Adv Virol
. 2025 Feb;
2025:5750575.
PMID: 39959654
Programmed cell death (PCD) is a well-studied cellular mechanism that plays a critical role in immune responses, developmental processes, and the maintenance of tissue homeostasis. However, viruses have developed diverse...
2.
Biray Avci C, Bagca B, Shademan B, Takanlou L, Takanlou M, Nourazarian A
Biochim Biophys Acta Rev Cancer
. 2024 Dec;
1880(1):189250.
PMID: 39701327
Cancer genomics plays a crucial role in oncology by enhancing our understanding of how genes drive cancer and facilitating the development of improved treatments. This field meticulously examines various cancers'...
3.
Dehghan B, Abolhasanzadeh N, Shademan B, Nourazarian A
Front Mol Biosci
. 2024 Dec;
11:1382555.
PMID: 39629040
This review delves into the intricate biological underpinnings of pain perception. It encompasses nociceptive signaling pathways, the molecular mechanisms involved, and the subjective experience of discomfort in humans. The initial...
4.
Amiri M, Moaveni A, Zolbin M, Shademan B, Nourazarian A
Front Immunol
. 2024 Nov;
15:1462697.
PMID: 39582866
Optimizing cancer treatment has become a pivotal goal in modern oncology, with advancements in immunotherapy and genetic engineering offering promising avenues. CAR-T cell therapy, a revolutionary approach that harnesses the...
5.
Biray Avci C, Bagca B, Shademan B, Takanlou L, Takanlou M, Nourazarian A
Funct Integr Genomics
. 2024 Oct;
24(5):182.
PMID: 39365298
This review analyzes the application of machine learning (ML) in oncological pharmacogenomics, focusing on customizing chemotherapy treatments. It explores how ML can analyze extensive genomic, proteomic, and other omics datasets...
6.
Shademan B, Yousefi H, Nourazarian A
Adv Pharm Bull
. 2024 Aug;
14(2):419-425.
PMID: 39206401
Purpose: Alzhеimеr's disеasе (AD) is thе most prеvalеnt form of dеmеntia globally. Rеsеarch links thе incrеasе of rеactivе oxidativе spеciеs (ROS) to thе pathogеnеsis of AD; thus, this study invеstigatеd...
7.
Barmaki H, Nourazarian A, Shademan B, Khaki-Khatibi F
Neurochem Int
. 2024 Aug;
179:105827.
PMID: 39111406
A recent study showed that while autophagy is usually tied to protein and organelle turnover, it can also play dual roles in neurodegenerative diseases. Traditionally, autophagy was seen as protective...
8.
Moaveni A, Amiri M, Shademan B, Farhadi A, Behroozi J, Nourazarian A
Front Mol Biosci
. 2024 Jun;
11:1382190.
PMID: 38836106
Pediatric cancers represent a tragic but also promising area for gene therapy. Although conventional treatments have improved survival rates, there is still a need for targeted and less toxic interventions....
9.
Biray Avci C, Bagca B, Shademan B, Takanlou L, Takanlou M, Nourazarian A
Front Cell Dev Biol
. 2024 Jun;
12:1401504.
PMID: 38835507
Cancer therapy is on the brink of a significant transformation with the inclusion of patient-derived organoids (PDOs) in drug development. These three-dimensional cell cultures, directly derived from a patient's tumor,...
10.
Abolhasanzadeh N, Sarabandi S, Dehghan B, Karamad V, Biray Avci C, Shademan B, et al.
Front Immunol
. 2024 May;
15:1333563.
PMID: 38807590
Breast cancer stands as the most prevalent form of cancer among women globally, influenced by a combination of genetic and environmental factors. Recent studies have investigated changes in microRNAs (miRNAs)...